CAMB

enzochleated amphotericin B · Matinas Biopharma Nanotechnologies, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAMB, covering 2018-10-05 to 2018-10-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC) [Phase 2]

See pricing